5GA-17962-36610
1 vaccination
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 017 / MA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-05
Registered in v-safe
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Redness · Fatigue or tirednessAdult check-in
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Cold sweat, Fatigue, Pyrexia — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: I signed up for vsafe 2 days after receiving the shot. The first day I had a chills, cold sweats, and a fever (100-101 range). The second day was a low grade fever and fatigue. Not sure how to retroactively report this.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Janssen/Johnson & Johnson |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): I signed up for vsafe 2 days after receiving the shot. The first day I had a chills, cold sweats, and a fever (100-101 range). The second day was a low grade fever and fatigue. Not sure how to retroactively report this.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release